Evidence map›Paper›PMID 35574300›Full record

SynthesisFrontiers in oncology2022

Epidemiological Evidence Between Variants in Matrix Metalloproteinases-2, -7, and -9 and Cancer Risk.

Chenglu Huang, Suqin Xu, Zhilin Luo, Dong Li, Rui Wang, Tianhu Wang

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Tozasertib + cisplatin inhibits proliferation, migration, and induces apoptosis in esophageal carcinoma cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chenglu HuangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Suqin XuDepartment of Radiology, Chongqing University Cancer Hospital, Chongqing, China.
Zhilin LuoDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Dong LiDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Rui WangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Tianhu WangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Medical University · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Matrix metalloproteinases ( Methods: PubMed, Web of Science, and Medline were systemically searched, and data were extracted from all eligible studies so as to investigate the susceptibility of Results: The associations between the variants of Conclusions: These findings support the relations between variants of

Indexed as

cancergenematrix metalloproteinasesmeta-analysisvariant

Identifiers

PMID35574300
PMCPMC9095957
OpenAlexW4224998077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.